Constant worry of redundancies - Avaliação de funcionários no cargo de Funcionário confidencial na empresa Parexel
Ver todas as avaliações (3645)Prós
The people, the office is clean
Contras
constant changes to processes without adequate training. Because there have been so many restructures staff are always worried that redundancies are pending
Resposta da empresa Parexel5yAs a forward thinking company we at Parexel are always evolving, putting the patient at the heart of what we do. To become the market-leading provider of Clinical, Consulting and Commercial solutions has required optimizing our business structure and workforce to meet customer needs and accelerate growth. We have aligned our resources and operations with customer demand. We did not take these actions lightly, and as a company we are always committed to transparent communication throughout while keeping our colleagues, customers and patient%E2%80%99s needs at the forefront of our mind and heart.
Outras avaliações de funcionários
Ver todas as avaliações (3645)- 5,0Clinical Research AssociateFuncionário(a) atualWaldorf, MD
Prós
Great working environment for all staff
Contras
I don't have a con to share right now
- 2,0Line ManagerFuncionário(a) atual, mais de 3 anos
Prós
They utilize numerous trackers and systems to efficiently organize information for managers, making it one of the most impressive setups I've encountered in any CRO
Contras
Since being acquired by a private equity firm, it appears that the company prioritizes profit over leadership quality. For instance, communication among leaders is lacking; promises of pay increases to CRAs were reneged upon without proper notification, shifting the responsibility to line managers. Additionally, during town halls and meetings, leadership paints a positive financial picture but fails to deliver bonuses or even a year-end dinner for employees. They also need to focus on hiring talented COLs as LM are asked to do tasks that should be handled by study team. LM roles are becoming more of a glorified COL rather than focusing on development of CRAs.